QQ客服 官方微博 反馈留言

	Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways
	Lai, Haoqiang[1]; Fu, Xiaoyan[1]; Sang, Chengcheng[1]; Hou, Liyuan[1]; Feng, Pengju[1]; Li, Xiaoling[2]; Chen, Tianfeng[1]
	2018
卷号	13期号:11页码:1447
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4307283
专题	暨南大学
作者单位	1.[1]Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Jinan Univ, Inst Food Safety & Nutr, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Lai, Haoqiang[1],Fu, Xiaoyan[1],Sang, Chengcheng[1],et al. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways[J],2018,13(11):1447.
APA	Lai, Haoqiang[1].,Fu, Xiaoyan[1].,Sang, Chengcheng[1].,Hou, Liyuan[1].,Feng, Pengju[1].,...&Chen, Tianfeng[1].(2018).Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways.,13(11),1447.
MLA	Lai, Haoqiang[1],et al."Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways".13.11(2018):1447.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。